These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 27411590)

  • 41. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC.
    Grohmann M; Wiede F; Dodd GT; Gurzov EN; Ooi GJ; Butt T; Rasmiena AA; Kaur S; Gulati T; Goh PK; Treloar AE; Archer S; Brown WA; Muller M; Watt MJ; Ohara O; McLean CA; Tiganis T
    Cell; 2018 Nov; 175(5):1289-1306.e20. PubMed ID: 30454647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.
    Arendt BM; Teterina A; Pettinelli P; Comelli EM; Ma DWL; Fung SK; McGilvray ID; Fischer SE; Allard JP
    Nutrition; 2019 Jun; 62():100-107. PubMed ID: 30870804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-17A inhibits cell autophagy under starvation and promotes cell migration via TAB2/TAB3-p38 mitogen-activated protein kinase pathways in hepatocellular carcinoma.
    Zhou Y; Wu PW; Yuan XW; Li J; Shi XL
    Eur Rev Med Pharmacol Sci; 2016; 20(2):250-63. PubMed ID: 26875893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extracellular Vesicles as Inflammatory Drivers in NAFLD.
    Srinivas AN; Suresh D; Santhekadur PK; Suvarna D; Kumar DP
    Front Immunol; 2020; 11():627424. PubMed ID: 33603757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage.
    Tummala KS; Gomes AL; Yilmaz M; Graña O; Bakiri L; Ruppen I; Ximénez-Embún P; Sheshappanavar V; Rodriguez-Justo M; Pisano DG; Wagner EF; Djouder N
    Cancer Cell; 2014 Dec; 26(6):826-839. PubMed ID: 25453901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene Therapy for Hepatocellular Carcinoma Using Adenoviral Vectors Delivering a Gene Encoding IL-17A-Neutralizing Antibody Fragments.
    Zou H; Tuhin IJ; Monty MA; Luo S; Shao J; Yan Z; Yu L
    Hum Gene Ther; 2020 Oct; 31(19-20):1074-1085. PubMed ID: 32390483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
    Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
    Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neutrophil extracellular traps enriched with IL-1β and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis.
    Arelaki S; Koletsa T; Sinakos E; Papadopoulos V; Arvanitakis K; Skendros P; Akriviadis E; Ritis K; Germanidis G; Hytiroglou P
    Virchows Arch; 2022 Sep; 481(3):455-465. PubMed ID: 35503185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation.
    Shen T; Chen X; Li Y; Tang X; Jiang X; Yu C; Zheng Y; Guo H; Ling W
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1510-1518. PubMed ID: 28153707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis.
    Marinović S; Lenartić M; Mladenić K; Šestan M; Kavazović I; Benić A; Krapić M; Rindlisbacher L; Cokarić Brdovčak M; Sparano C; Litscher G; Turk Wensveen T; Mikolašević I; Fučkar Čupić D; Bilić-Zulle L; Steinle A; Waisman A; Hayday A; Tugues S; Becher B; Polić B; Wensveen FM
    Sci Immunol; 2023 Sep; 8(87):eadd1599. PubMed ID: 37774007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model.
    Sakamoto H; Miyanishi K; Tanaka S; Ito R; Hamaguchi K; Sakurada A; Sato M; Kubo T; Osuga T; Murase K; Takada K; Nakabeppu Y; Kobune M; Kato J
    Sci Rep; 2021 Feb; 11(1):3599. PubMed ID: 33574380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD4
    Her Z; Tan JHL; Lim YS; Tan SY; Chan XY; Tan WWS; Liu M; Yong KSM; Lai F; Ceccarello E; Zheng Z; Fan Y; Chang KTE; Sun L; Chang SC; Chin CL; Lee GH; Dan YY; Chan YS; Lim SG; Chan JKY; Chandy KG; Chen Q
    Front Immunol; 2020; 11():580968. PubMed ID: 33013934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NAD(+) supplementation as a novel approach to cURIng HCC?
    Mederacke I; Schwabe RF
    Cancer Cell; 2014 Dec; 26(6):777-778. PubMed ID: 25490440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.
    Kumar R; Goh BG; Kam JW; Chang PE; Tan CK
    Clin Mol Hepatol; 2020 Apr; 26(2):196-208. PubMed ID: 31914720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.
    Moreno-Fernandez ME; Giles DA; Stankiewicz TE; Sheridan R; Karns R; Cappelletti M; Lampe K; Mukherjee R; Sina C; Sallese A; Bridges JP; Hogan SP; Aronow BJ; Hoebe K; Divanovic S
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma.
    Casagrande V; Mauriello A; Bischetti S; Mavilio M; Federici M; Menghini R
    Sci Rep; 2017 Jul; 7(1):6747. PubMed ID: 28751722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinoma.
    Yan J; Liu XL; Xiao G; Li NL; Deng YN; Han LZ; Yin LC; Ling LJ; Liu LX
    PLoS One; 2014; 9(5):e96080. PubMed ID: 24867183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells.
    Goonetilleke M; Kuk N; Correia J; Hodge A; Moore G; Gantier MP; Yeoh G; Sievert W; Lim R
    Stem Cell Res Ther; 2021 Jul; 12(1):429. PubMed ID: 34321089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of chromatin-accessible domains in non-alcoholic steatohepatitis-derived hepatocellular carcinoma.
    Dechassa ML; Tryndyak V; de Conti A; Xiao W; Beland FA; Pogribny IP
    Mol Carcinog; 2018 Aug; 57(8):978-987. PubMed ID: 29603380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis.
    Tsai YW; Jeng KS; He MK; Hsieh YW; Lai HH; Lai CY; Huang CC; Chang CF; Huang CT; Her GM
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.